Tools to assess (and achieve?) long-term asthma control

Respiratory Medicine

Volumn 98, Issue SUPPL. 2, 2004, Pages

  Magnan, Antoine ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Asthma control; Bronchial hyperreactivity; Eosinophilia; Exacerbations; Exhaled NO; Induced sputum

Indexed keywords

ADENOSINE PHOSPHATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; LONG ACTING DRUG; NITRIC OXIDE; PREDNISOLONE;

ANALYTIC METHOD; AROUSAL; ARTICLE; ASTHMA; CLINICAL FEATURE; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG USE; EOSINOPHIL; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION TEST; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCIBILITY; SCORING SYSTEM; SPUTUM ANALYSIS;

ASTHMA; BREATH TESTS; BRONCHIAL PROVOCATION TESTS; EARLY DIAGNOSIS; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMANS; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; QUESTIONNAIRES; SPUTUM; TREATMENT OUTCOME;

EID: 11144284178     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.07.011     Document Type: Article

References (11)

1. R. Pauwels S. Pedersen W. Busse et al. Early intervention with budesonide in mild persistent asthma, a randomised, double-blind trial Lancet 361 2003 1066-1067
2. A. Tattersfield D. Postma P. Barnes et al. Exacerbations of asthma a descriptive study of 425 severe exacerbations. The FACET International Study Group Am J Respir Crit Care Med 160 1999 594-599
3. A. Jatakanon S. Lim P. Barnes Changes in sputum eosinophils predict loss of asthma control Am J Respir Crit Care Med 161 2000 64-72
4. M. Pizzichini E. Pizzichini L. Lelland et al. Prednisone-dependent asthma inflammatory indices in induced sputum Eur Respir J 13 1999 5-7
5. E. Juniper P. O'Byrne P. Ferrie D. King J. Roberts Measuring asthma control. Clinic questionnaire or daily diary Am J Respir Crit Care Med 162 2000 1330-1334
6. A. Jatakanon S. Kharitonov S. Lim P. Barnes Effect of differing doses of budesonide on markers of airway inflammation in patients with mild asthma Thorax 54 1999 108-114
7. J. Sont L. Willems E. Bel et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment, The AMPUL Study Group Am J Respir Crit Care Med 159 1999 1043-1051
8. G. Prosperini K. Rajakulasingam R. Cacciola et al. Changes in sputum counts and airway hyperresponsiveness after budesonide monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation J Allergy Clin Immunol 110 2002 855-861
9. R. Green C. Brightling S. Mckenna et al. Asthma exacerbations and sputum eosinophil counts a randomised controlled trial Lancet 360 2002 1715-1721
10. K. Parameswaran R. Leigh F. Hargreave Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma J Allergy Clin Immunol 104 1999 502-503
11. D. Payne Nitric oxide in allergic airway inflammation Curr Opin Allergy Clin Immunol 3 2003 133-137